In the past week, IFRX stock has gone up by 2.25%, with a monthly gain of 51.67% and a quarterly plunge of -0.55%. The volatility ratio for the week is 5.67%, and the volatility levels for the last 30 days are 7.37% for InflaRx N.V The simple moving average for the past 20 days is 10.37% for IFRX’s stock, with a 5.46% simple moving average for the past 200 days.
Is It Worth Investing in InflaRx N.V (NASDAQ: IFRX) Right Now?
The 36-month beta value for IFRX is also noteworthy at 1.51. There are mixed opinions on the stock, with 6 analysts rating it as a “buy,” 1 rating it as “overweight,” 1 rating it as “hold,” and 0 rating it as “sell.”
The public float for IFRX is 57.08M, and at present, short sellers hold a 1.98% of that float. The average trading volume of IFRX on May 23, 2025 was 327.53K shares.
IFRX) stock’s latest price update
InflaRx N.V (NASDAQ: IFRX) has experienced a rise in its stock price by 7.69 compared to its previous closing price of 1.69. However, the company has seen a gain of 2.25% in its stock price over the last five trading days. globenewswire.com reported 2025-05-22 that JENA, Germany, May 22, 2025 (GLOBE NEWSWIRE) — InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced that the Company will participate in multiple investor conferences in June and July 2025.
Analysts’ Opinion of IFRX
Many brokerage firms have already submitted their reports for IFRX stocks, with Cantor Fitzgerald repeating the rating for IFRX by listing it as a “Overweight.” The predicted price for IFRX in the upcoming period, according to Cantor Fitzgerald is $10 based on the research report published on April 29, 2025 of the current year 2025.
Guggenheim, on the other hand, stated in their research note that they expect to see IFRX reach a price target of $8. The rating they have provided for IFRX stocks is “Buy” according to the report published on April 05th, 2023.
IFRX Trading at 35.95% from the 50-Day Moving Average
After a stumble in the market that brought IFRX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -35.35% of loss for the given period.
Volatility was left at 7.37%, however, over the last 30 days, the volatility rate increased by 5.67%, as shares surge +37.88% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +47.97% upper at present.
During the last 5 trading sessions, IFRX rose by +2.25%, which changed the moving average for the period of 200-days by +31.88% in comparison to the 20-day moving average, which settled at $1.6490. In addition, InflaRx N.V saw -26.32% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for IFRX
Current profitability levels for the company are sitting at:
- -412.52 for the present operating margin
- -22.94 for the gross margin
The net margin for InflaRx N.V stands at -344.66. The total capital return value is set at -0.76. Equity return is now at value -62.38, with -54.58 for asset returns.
Based on InflaRx N.V (IFRX), the company’s capital structure generated 0.01 points at debt to capital in total, while cash flow to debt ratio is standing at -67.89. The debt to equity ratio resting at 0.01. The interest coverage ratio of the stock is -2365.34.
Currently, EBITDA for the company is -45.55 million with net debt to EBITDA at 1.02. When we switch over and look at the enterprise to sales, we see a ratio of 473.03. The receivables turnover for the company is 0.08for trailing twelve months and the total asset turnover is 0.0. The liquidity ratio also appears to be rather interesting for investors as it stands at 5.28.
Conclusion
In summary, InflaRx N.V (IFRX) has had a mixed performance as of late. Analysts have bullish opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
